Zynrelef (bupivacaine and meloxicam), 400 mg bupivacaine and 12 mg meloxicam single dose application, packaged in a kit, Rx only, Manufactured for Heron Therapeutics, Inc., San Diego, CA, NDC 47426-301-02
Published August 24, 2022 · Recall initiated: August 2, 2022
Summary
FDA records drug Class III recall D-1335-2022, published August 24, 2022 and initiated August 2, 2022. Recalling firm: HERON THERAPEUTICS, INC.; Status: Terminated; Reported quantity: 1790 kits; Lot: Lot #: 01126739, Exp 7/31/2023. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Defective Delivery System: An incorrect 10 mL (12 mL) Luer (slip) syringe packaged in one lot of Zynrelef 400 mg/12 mg kit
What to do
Voluntary: Firm initiated · Letter
Get an email if ZYNRELEF has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- ZYNRELEF
- Manufacturer
- HERON THERAPEUTICS, INC.
- Distributor
- U.S.A. Nationwide
- Lot
- Lot #: 01126739, Exp 7/31/2023
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAM Hand Sanitizer Ethyl Alcohol Antiseptic 80%v/v, Topical Solution 128 oz/3,785 mL, Made in Mexico by: GrupoAugust 24, 2022
- FDARifampin Capsules, USP, 150 mg, 30 count HDPE bottles, Rx Only, Manufactured for Lupin Pharmaceuticals, Inc.,August 24, 2022
- FDAPF-Neostigmine Methylsulfate Injection, USP, 3 mg/3 mL (1 mg/mL), One 3 mL Unit-Dose Vial, packaged in 30 x 3August 24, 2022
- FDA3D Systems VSP Reconstruction, Model: VSPR-301 Product: Scapula Marking Guide (Anatomically Shaped), Rx Only,August 17, 2022
- FDAThe Cholestech LDX® System combines enzymatic methodology and solidphase technology to measure totalAugust 17, 2022
- FDACrome Implantable Cardioverter Defibrillators: a. Crome VR ICD, Model Numbers: DVPC3D1, DVPC3D4; b. Crome DRAugust 17, 2022
Questions about this recall
Was Zynrelef (bupivacaine and meloxicam), 400 mg bupivacaine and 12 mg meloxicam single dose application, packaged in a kit, Rx only, Manufactured for Heron Therapeutics, Inc., San Diego, CA, NDC 47426-301-02 recalled?
Yes. FDA published recall D-1335-2022 on August 24, 2022. Reported hazard: Defective Delivery System: An incorrect 10 mL (12 mL) Luer (slip) syringe packaged in one lot of Zynrelef 400 mg/12 mg kit
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: ZYNRELEF.